The company was completely restructured in beginning of 2008 and has at that time made a new business plan which includes manufacturing in a new WHO-GMP certified factory by all GMP standards and guidelines. Feracov products are currently in Phase 2 of clinical trials and once all documentation is finished the first batch of products should be available in September 2009 (as previously announced May 2009 was not possible).